PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Study finds people on anti-obesity medications cut both weight and alcohol consumption

Researchers found moderate and heavy drinkers were most likely to reduce alcohol intake while on all types of anti-obesity medications

Study finds people on anti-obesity medications cut both weight and alcohol consumption
2024-12-04
(Press-News.org) DETROIT (Dec. 04, 2024)—Losing weight with anti-obesity medications (AOM) also resulted in decreased alcohol consumption for about half of the participants in a new study appearing in the current issue of JAMA Network Open.

The research, led by Lisa Miller-Matero, PhD, an associate scientist and Associate Director of Health Services Research at Henry Ford Health, adds to a growing body of research that suggests medications such as Ozempic or Wegovy could be adapted to treat substance use disorders.

“This was different from past research in that we included a variety of anti-obesity medications and looked at changes in alcohol use among people who reported casual consumption,” Miller-Matero said. “Other work primarily only included glucagon-like peptide-1 receptor agonists (GLP-1 RAs) among individuals with substance use disorders. We also compared GLP-1 RAs to metformin and bupropion/naltrexone, which are other anti-obesity medications.”

Researchers examined the drinking habits of 14,000 WeightWatchers members who began taking an AOM between January 2022 and August 2023 and refilled the same AOM between October 2023 and November 2023.

“What was exciting was that those who were drinking at higher, or even what is considered hazardous levels, had a greater likelihood of reducing alcohol use,” Miller-Matero said.

Prior to beginning their medication, participants were asked if their average weekly alcohol consumption was light (1-3 drinks per week for women and 1-6 drinks per week for men), moderate (4-6 per week for women and 7-14 per week for men), or heavy (7+ per week for women and 15+ per week for men.) Participants updated their consumption level again at the time of refill.

Among the approximately 7,500 participants who initially reported alcohol use, about 3,400 reported decreasing their category of alcohol use, with the biggest reduction reported by people originally in the moderate and heavy drinking categories. All types of AOMs were associated with reduced alcohol use.

“People on the WeightWatchers program who have used AOM have said: ‘My whole life I’ve been a social drinker, but now I’m not craving my glass of red wine,’ or ‘I’m drinking the same or less than before and am having the worst hangover of my life,’ therefore deterring their interest in alcohol,” said study senior author and WeightWatchers Chief Nutrition Officer Michelle Cardel, PhD, RD.

Miller-Matero says further research would help determine if the medications led to decreased alcohol use or if participants changed their drinking habits because they were consuming fewer calories and making healthier lifestyle choices. 

She said the findings also warrant further research into the use of anti-obesity medications for treating substance use.

###

 

END


[Attachments] See images for this press release:
Study finds people on anti-obesity medications cut both weight and alcohol consumption

ELSE PRESS RELEASES FROM THIS DATE:

ETSU secures $900k defense grant

2024-12-04
The U.S. Department of Defense has awarded the ETSU Research Corporation over $900,000 as part of the Defense Industrial Base Consortium, an investment that will help create new opportunities to foster regional innovation in sustainable industrial manufacturing in the Appalachian region. “Our goal is to enhance the prosperity of our region by connecting local innovation with opportunities in global emerging markets,” said Eric Jorgenson, vice president of evelopment for the ETSU Research Corporation. “This project is another key part of the foundation of a robust biomanufacturing ecosystem in ...

ETSU researcher earns grant to build flood dashboard using generative AI

2024-12-04
An East Tennessee State University researcher is developing a cutting-edge dashboard using generative artificial intelligence to assist in monitoring flooding in Central Appalachia.  The pilot project, titled "Leveraging Generative Artificial Intelligence (AI) for Automated Climate Resilience Dashboards: A Case Study on Flood Monitoring in Central Appalachia," has recently secured $20,000 in funding from the Earth Science Information Partners (ESIP) Lab.  Dr. Qian Huang from ETSU’s Center for Rural Health and Research, in collaboration with Dr. ...

AI-enabled analysis of images meant to catch one disease can reveal others

2024-12-04
With the help of an AI tool, computed tomography (CT) scans taken originally to look for tumors or bleeding or infections, also revealed calcium buildup in arteries, a sign of worsening cardiovascular disease.   This is the result of a new study led by researchers at NYU Langone Health and an example of a new trend in “opportunistic screening,” wherein radiologists repurpose existing medical images to diagnose illnesses beyond what the scan was originally designed to find. Presented at the annual Radiological Society of North America ...

Key objections to collecting immigration status data in national health surveys

Key objections to collecting immigration status data in national health surveys
2024-12-04
Nativity—characterized by place of birth, duration of residence in the host country, citizenship and immigration status—greatly influences the health of foreign-born individuals in the United States (U.S.). Despite this, many national health surveys omit questions about these dimensions of nativity, particularly immigration status. This omission limits the ability to assess health disparities across diverse immigrant subgroups and develop evidence-based policies and targeted interventions. To navigate this limitation, researchers rely on proxy measures or imputations ...

Clinical trial of device aims to induce ovulation in women with polycystic ovary syndrome

Clinical trial of device aims to induce ovulation in women with polycystic ovary syndrome
2024-12-04
Physicians at the University of Oklahoma Health Sciences in Oklahoma City are leading a national clinical trial to help women with polycystic ovary syndrome (PCOS)-related infertility who want to become pregnant. The trial, called REBALANCE, studies the safety and effectiveness of an investigational device developed by May Health that is designed to restore ovulation disrupted by PCOS. OU Health reproductive endocrinologist Karl Hansen, M.D., Ph.D., chair of the Department of Obstetrics and Gynecology at the OU College of Medicine, is leading the trial for ...

Natural ‘biopesticide’ against malaria mosquitoes successful in early field tests

2024-12-04
An experimental bacteria-derived biopesticide is highly effective in killing malaria-carrying mosquitoes, including those that have developed resistance to chemical pesticides, according to initial field tests led by researchers at the Johns Hopkins Bloomberg School of Public Health. The biopesticide is a powder made from the dead cells of a common soil-dwelling bacterial species. The researchers showed that the biopesticide efficiently kills both ordinary and chemical-pesticide-resistant mosquitoes when included in standard baits. ...

NSF-Piedmont Triad Regenerative Medicine Engine (PTRME) awards $2.5 million in grants to drive economic growth

2024-12-04
WINSTON-SALEM, N.C. – December 4, 2024 — The Piedmont Triad Regenerative Medicine Engine (PTRME), funded by the National Science Foundation (NSF), has announced a groundbreaking investment of $2.5 million in the region’s regenerative medicine industry through its inaugural Ecosystem Building Grant program. This milestone underscores PTRME’s leadership in regenerative medicine and commitment to positioning the Piedmont Triad as a global hub for innovation. Six innovative companies have been awarded grants ...

How plant enzymes can adapt to higher temperatures

2024-12-04
  Images EAST LANSING, Mich. – As global temperatures rise, it’s imperative that plants can adapt to new and changing conditions.  As global temperatures rise, it’s imperative that plants can adapt to new and changing conditions.  Michigan State University researchers from the Walker lab are looking at ways to give plants an assist. More specifically, their research aims to help plants adapt to changing temperatures by introducing engineered enzymes that will increase plants’ heat tolerance. “I would say that the main goal of our research is to prepare plants for elevated temperatures because, with climate change, ...

The Gerontological Society of America congratulates new 2024 Awardees

2024-12-04
The Gerontological Society of America (GSA) — the country’s largest interdisciplinary organization devoted to the field of aging — is proud to acknowledge the work of 34 outstanding individuals through its prestigious awards program. GSA salutes outstanding research, recognizes distinguished leadership in teaching and service, and fosters new ideas through a host of awards. Nominated by their peers, the recipients’ achievements serve as milestones in the history and development of gerontology. The awardees were honored at various ...

New facility for evaluating hydrogen-compatible materials now complete

New facility for evaluating hydrogen-compatible materials now complete
2024-12-04
1. NIMS has established and begun operating a new testing facility to evaluate the mechanical properties of materials exposed to low-temperature hydrogen environments. This facility can create hydrogen conditions across a broader range of temperatures and pressures than any other facility of its kind in the world. It is designed to assess the properties of materials when in contact with low-temperature gaseous or liquefied hydrogen, with the goal of developing cost-effective materials for hydrogen supply chains. This approach is expected to reduce the cost of producing and operating ...

LAST 30 PRESS RELEASES:

Early adult mortality is higher than expected in US post-COVID

Recycling lithium-ion batteries cuts emissions and strengthens supply chain

Study offers new hope for relieving chronic pain in dialysis patients

How does the atmosphere affect ocean weather?

Robots get smarter to work in sewers

Speech Accessibility Project data leads to recognition improvements on Microsoft Azure

Tigers in the neighborhood: How India makes room for both tigers and people

Grove School’s Arthur Paul Pedersen publishes critical essay on scientific measurement literacy

Moffitt study finds key biomarker to predict KRASG12C inhibitor effectiveness in lung cancer

Improving blood transfusion monitoring in critical care patients: Insights from diffuse optics

Powerful legal and financial services enable kleptocracy, research shows

Carbon capture from constructed wetlands declines as they age

UCLA-led study establishes link between early side effects from prostate cancer radiation and long-term side effects

Life cycles of some insects adapt well to a changing climate. Others, not so much.

With generative AI, MIT chemists quickly calculate 3D genomic structures

The gut-brain connection in Alzheimer’s unveiled with X-rays

NIH-funded clinical trial will evaluate new dengue therapeutic

Sound is a primary issue in the lives of skateboarders, study shows

Watch what you eat: NFL game advertisements promote foods high in fat, sodium

Red Dress Collection Concert hosted by Sharon Stone kicks off American Heart Month

One of the largest studies on preterm birth finds a maternal biomarker test significantly reduces neonatal morbidities and improves neonatal outcomes

One of the largest studies of its kind finds early intervention with iron delivered intravenously during pregnancy is a safe and effective treatment for anemia

New Case Western Reserve University study identifies key protein’s role in psoriasis

First-ever ethics checklist for portable MRI brain researchers

Addressing 3D effects of clouds for significant improvements of climate models

Gut microbes may mediate the link between drinking sugary beverages and diabetes risk

Ribosomes team up in difficult situations, new technology shows

Mortality trends among adults ages 25-44 in the US

Discontinuation and reinitiation of dual-labeled GLP-1 receptor agonists among us adults with overweight or obesity

Ultraprocessed food consumption and obesity development in Canadian children

[Press-News.org] Study finds people on anti-obesity medications cut both weight and alcohol consumption
Researchers found moderate and heavy drinkers were most likely to reduce alcohol intake while on all types of anti-obesity medications